MSTPW Financials 07/16/2014 04:38:21 Mast Therape

MSTPW Financials 07/16/2014 04:38:21
Mast Therapeutics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - 489
Cost of Revenue - - - -
Gross Profit - - - 489
Operating Expenses
Research and Development 12,902 8,088 5,758 3,689
Sales, General and Admin. 8,597 7,450 7,601 5,320
Non-Recurring Items - - - -
Other 40 90 38 20
Operating Income (21,539) (15,628) (13,397) (8,540)
Income From Continuing Operations
Add'l Income/Expense Items 59 69 137 90
Earnings Before Interest and Tax (21,480) (15,559) (13,260) (8,449)
Interest Expense - - - 2
Earnings Before Tax (21,480) (15,559) (13,260) (8,451)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (21,480) (15,559) (13,260) (8,451)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (21,480) (15,559) (13,260) (8,451)
Preferred Stock and Other Adjustments - - - (5,640)
Net Income Applicable to Common Shareholders (21,480) (15,559) (13,260) (14,091)